Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

F. Perrone; M. De Laurentiis; S. De Placido; M. Orditura; S. Cinieri; F. Riccardi; A.S. Ribecco; C. Putzu; L. Del Mastro; E. Rossi; V. Tinessa; A.M. Mosconi; F. Nuzzo; F. Di Rella; A. Gravina; G. Iodice; G. Landi; C. Pacilio; V. Forestieri; R. Lauria; A. Fabbri; T. Ibrahim; E. De Maio; S. Barni; S. Gori; V. Simeon; L. Arenare; G. Daniele; M.C. Piccirillo; N. Normanno; A. de Matteis; C. Gallo

doi:10.1016/j.ejca.2019.05.004

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

F. Perrone, M. De Laurentiis, S. De Placido, M. Orditura, S. Cinieri, F. Riccardi, A.S. Ribecco, C. Putzu, L. Del Mastro, E. Rossi, V. Tinessa, A.M. Mosconi, F. Nuzzo, F. Di Rella, A. Gravina, G. Iodice, G. Landi, C. Pacilio, V. Forestieri, R. LauriaA. Fabbri, T. Ibrahim, E. De Maio, S. Barni, S. Gori, V. Simeon, L. Arenare, G. Daniele, M.C. Piccirillo, N. Normanno, A. de Matteis, C. Gallo

Research output: Contribution to journal › Article › peer-review

Original language	Italian
Pages (from-to)	178-186
Number of pages	9
Journal	European Journal of Cancer
Volume	118
DOIs	https://doi.org/10.1016/j.ejca.2019.05.004
Publication status	Published - 2019

Access to Document

10.1016/j.ejca.2019.05.004

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066319293&doi=10.1016%2fj.ejca.2019.05.004&partnerID=40&md5=7af60059d9e3a83b9d1780ed4cfeea8c

Cite this

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., ... Gallo, C. (2019). Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial. European Journal of Cancer, 118, 178-186. https://doi.org/10.1016/j.ejca.2019.05.004

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial. / Perrone, F.; De Laurentiis, M.; De Placido, S.; Orditura, M.; Cinieri, S.; Riccardi, F.; Ribecco, A.S.; Putzu, C.; Del Mastro, L.; Rossi, E.; Tinessa, V.; Mosconi, A.M.; Nuzzo, F.; Di Rella, F.; Gravina, A.; Iodice, G.; Landi, G.; Pacilio, C.; Forestieri, V.; Lauria, R.; Fabbri, A.; Ibrahim, T.; De Maio, E.; Barni, S.; Gori, S.; Simeon, V.; Arenare, L.; Daniele, G.; Piccirillo, M.C.; Normanno, N.; de Matteis, A.; Gallo, C.

In: European Journal of Cancer, Vol. 118, 2019, p. 178-186.

Research output: Contribution to journal › Article › peer-review

Perrone, F , De Laurentiis, M, De Placido, S, Orditura, M, Cinieri, S, Riccardi, F, Ribecco, AS, Putzu, C, Del Mastro, L , Rossi, E, Tinessa, V, Mosconi, AM, Nuzzo, F , Di Rella, F , Gravina, A, Iodice, G, Landi, G, Pacilio, C, Forestieri, V, Lauria, R, Fabbri, A , Ibrahim, T, De Maio, E, Barni, S, Gori, S, Simeon, V, Arenare, L , Daniele, G , Piccirillo, MC , Normanno, N, de Matteis, A & Gallo, C 2019, 'Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial', European Journal of Cancer, vol. 118, pp. 178-186. https://doi.org/10.1016/j.ejca.2019.05.004

Perrone, F. ; De Laurentiis, M. ; De Placido, S. ; Orditura, M. ; Cinieri, S. ; Riccardi, F. ; Ribecco, A.S. ; Putzu, C. ; Del Mastro, L. ; Rossi, E. ; Tinessa, V. ; Mosconi, A.M. ; Nuzzo, F. ; Di Rella, F. ; Gravina, A. ; Iodice, G. ; Landi, G. ; Pacilio, C. ; Forestieri, V. ; Lauria, R. ; Fabbri, A. ; Ibrahim, T. ; De Maio, E. ; Barni, S. ; Gori, S. ; Simeon, V. ; Arenare, L. ; Daniele, G. ; Piccirillo, M.C. ; Normanno, N. ; de Matteis, A. ; Gallo, C. / Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial. In: European Journal of Cancer. 2019 ; Vol. 118. pp. 178-186.

@article{13e5fc1becc64a4882314fc5d8855e7b,

title = "Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial",

author = "F. Perrone and {De Laurentiis}, M. and {De Placido}, S. and M. Orditura and S. Cinieri and F. Riccardi and A.S. Ribecco and C. Putzu and {Del Mastro}, L. and E. Rossi and V. Tinessa and A.M. Mosconi and F. Nuzzo and {Di Rella}, F. and A. Gravina and G. Iodice and G. Landi and C. Pacilio and V. Forestieri and R. Lauria and A. Fabbri and T. Ibrahim and {De Maio}, E. and S. Barni and S. Gori and V. Simeon and L. Arenare and G. Daniele and M.C. Piccirillo and N. Normanno and {de Matteis}, A. and C. Gallo",

note = "Cited By :3 Export Date: 25 February 2020",

year = "2019",

doi = "10.1016/j.ejca.2019.05.004",

language = "Italian",

volume = "118",

pages = "178--186",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

AU - Perrone, F.

AU - De Laurentiis, M.

AU - De Placido, S.

AU - Orditura, M.

AU - Cinieri, S.

AU - Riccardi, F.

AU - Ribecco, A.S.

AU - Putzu, C.

AU - Del Mastro, L.

AU - Rossi, E.

AU - Tinessa, V.

AU - Mosconi, A.M.

AU - Nuzzo, F.

AU - Di Rella, F.

AU - Gravina, A.

AU - Iodice, G.

AU - Landi, G.

AU - Pacilio, C.

AU - Forestieri, V.

AU - Lauria, R.

AU - Fabbri, A.

AU - Ibrahim, T.

AU - De Maio, E.

AU - Barni, S.

AU - Gori, S.

AU - Simeon, V.

AU - Arenare, L.

AU - Daniele, G.

AU - Piccirillo, M.C.

AU - Normanno, N.

AU - de Matteis, A.

AU - Gallo, C.

N1 - Cited By :3 Export Date: 25 February 2020

PY - 2019

Y1 - 2019

U2 - 10.1016/j.ejca.2019.05.004

DO - 10.1016/j.ejca.2019.05.004

M3 - Articolo

VL - 118

SP - 178

EP - 186

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -